BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25932808)

  • 1. Endomyocardial biopsy in Anderson-Fabry disease: The key in uncertain cases.
    Tschöpe C; Dominguez F; Canaan-Kühl S; Blaschke D; Kühl U; Pieske B; Haverkamp W
    Int J Cardiol; 2015; 190():284-6. PubMed ID: 25932808
    [No Abstract]   [Full Text] [Related]  

  • 2. Fabry cardiomyopathy in the female confirmed by endomyocardial biopsy.
    Broadbent JC; Edwards WD; Gordon H; Hartzler GO; Krawisz JE
    Mayo Clin Proc; 1981 Oct; 56(10):623-8. PubMed ID: 6268901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
    Pisani A; Riccio E; Cianciaruso B; Imbriaco M
    J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
    Veinot JP
    Circulation; 2002 Oct; 106(15):e73; author reply e73. PubMed ID: 12370238
    [No Abstract]   [Full Text] [Related]  

  • 5. Images in cardiovascular medicine. Myocardial fibrosis in fabry disease demonstrated by multislice computed tomography: comparison with biopsy findings.
    Funabashi N; Toyozaki T; Matsumoto Y; Yonezawa M; Yanagawa N; Yoshida K; Komuro I
    Circulation; 2003 May; 107(19):2519-20. PubMed ID: 12756193
    [No Abstract]   [Full Text] [Related]  

  • 6. Endomyocardial biopsy. Diagnosis of Fabry's disease in congestive cardiomyopathy.
    Maben P; Evans R; Lin J; Vaughan D
    J Kans Med Soc; 1983 Nov; 84(11):556-7. PubMed ID: 6417252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic problems in a 17-year-old patient with gastrointestinal manifestations of Fabry disease].
    Buda P; Wieteska-Klimczak A; Ksiazyk J; Smorczewska-Kiljan A; Gietka P; Czartoryska B; Tylki-Szymańska A
    Med Wieku Rozwoj; 2011; 15(1):69-72. PubMed ID: 21786514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Fabry disease with plural mass fibrosis observed in the thickened left ventricular wall.
    Nishimura K; Funabashi N; Takahashi Y; Hasegawa H; Takaoka H; Fujimoto Y; Kitagawa M; Nakatani Y; Kobayashi Y
    Int J Cardiol; 2016 Jan; 202():552-5. PubMed ID: 26447660
    [No Abstract]   [Full Text] [Related]  

  • 9. Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia.
    Martin L; Sturgess A; Sillence D; Murrell DF
    Australas J Dermatol; 2007 Feb; 48(1):40-2. PubMed ID: 17222302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group.
    Gal A; Hughes DA; Winchester B
    J Inherit Metab Dis; 2011 Apr; 34(2):509-14. PubMed ID: 21229318
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac manifestations of Fabry's disease. Report of a case with pulmonary regurgitation diagnosed on the basis of endomyocardial biopsy findings.
    Matsui S; Murakami E; Takekoshi N; Hiramaru Y; Kin T
    Jpn Circ J; 1977 Sep; 41(9):1023-36. PubMed ID: 410963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-galactosidase A deficiency (Fabry's disease) in a black Zimbabwean.
    Borok MZ; Gabriel R
    S Afr Med J; 1993 May; 83(5):350-1. PubMed ID: 8211434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient alpha-galactosidase A activity in plasma but no Fabry disease--a pitfall in diagnosis.
    Hoffmann B; Georg Koch H; Schweitzer-Krantz S; Wendel U; Mayatepek E
    Clin Chem Lab Med; 2005; 43(11):1276-7. PubMed ID: 16232095
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
    Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
    Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of Fabry disease in female carriers.
    Bird TD; Lagunoff D
    Ann Neurol; 1978 Dec; 4(6):537-40. PubMed ID: 217299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Fabry disease in patients with left ventricular hypertrophy.
    Mawatari K; Yasukawa H; Oba T; Nagata T; Togawa T; Tsukimura T; Kyogoku S; Ohshima H; Minami T; Sugi Y; Sakuraba H; Imaizumi T
    Int J Cardiol; 2013 Aug; 167(3):1059-61. PubMed ID: 23168011
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.
    Linthorst GE; Poorthuis BJ; Hollak CE
    J Am Coll Cardiol; 2008 May; 51(21):2082; author reply 2082-3. PubMed ID: 18498967
    [No Abstract]   [Full Text] [Related]  

  • 20. Anderson--Fabry disease.
    Pyeritz RE; Bender WL; Lipford EH
    Johns Hopkins Med J; 1982 May; 150(5):181-7. PubMed ID: 6281510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.